BOBCAT Trademark

Trademark Overview


On Tuesday, October 3, 2023, a trademark application was filed for BOBCAT with the United States Patent and Trademark Office. The USPTO has given the BOBCAT trademark a serial number of 98207353. The federal status of this trademark filing is REGISTERED as of Tuesday, May 20, 2025. This trademark is owned by Elixirgen Therapeutics, Inc.. The BOBCAT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, RNA dosage medium preparations carrying genes encoding proteins for treating or preventing genetic diseases; pharmaceutical preparations, namely, RNA dosage medium preparations carrying genes encoding proteins for treating or preventing infectious diseases; pharmaceutical preparations, namely, RNA dosage medium preparations carrying genes encoding proteins for treating or preventing cancers; pharmaceutical preparations, namely, RNA dosage medium preparations carrying genes encoding proteins for treating or preventing age-related diseases; pharmaceutical preparations, namely, RNA dosage medium preparations carrying genes encoding ribonucleoprotein constructs for gene editing being for the treatment of genetic disorders; pharmaceutical preparations, namely, RNA dosage medium preparations carrying genes encoding ribonucleoprotein constructs for treating genetic disorders in the nature of telomere shortening; pharmaceutical preparations, namely, RNA dos...
bobcat

General Information


Serial Number98207353
Word MarkBOBCAT
Filing DateTuesday, October 3, 2023
Status700 - REGISTERED
Status DateTuesday, May 20, 2025
Registration Number7804750
Registration DateTuesday, May 20, 2025
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 30, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, RNA dosage medium preparations carrying genes encoding proteins for treating or preventing genetic diseases; pharmaceutical preparations, namely, RNA dosage medium preparations carrying genes encoding proteins for treating or preventing infectious diseases; pharmaceutical preparations, namely, RNA dosage medium preparations carrying genes encoding proteins for treating or preventing cancers; pharmaceutical preparations, namely, RNA dosage medium preparations carrying genes encoding proteins for treating or preventing age-related diseases; pharmaceutical preparations, namely, RNA dosage medium preparations carrying genes encoding ribonucleoprotein constructs for gene editing being for the treatment of genetic disorders; pharmaceutical preparations, namely, RNA dosage medium preparations carrying genes encoding ribonucleoprotein constructs for treating genetic disorders in the nature of telomere shortening; pharmaceutical preparations, namely, RNA dosage medium preparations carrying genes encoding proteins for regenerative medicine in the nature of cell rejuvenation

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 12, 2023
Primary Code005
First Use Anywhere DateWednesday, November 6, 2024
First Use In Commerce DateWednesday, November 6, 2024

Trademark Owner History


Party NameElixirgen Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBaltimore, MD 21205

Party NameElixirgen Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBaltimore, MD 21205

Party NameElixirgen Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBaltimore, MD 21205

Trademark Events


Event DateEvent Description
Friday, October 6, 2023NEW APPLICATION ENTERED
Thursday, October 12, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 23, 2024ASSIGNED TO EXAMINER
Wednesday, May 29, 2024NON-FINAL ACTION E-MAILED
Wednesday, May 29, 2024NON-FINAL ACTION WRITTEN
Wednesday, May 29, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 20, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 20, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 20, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 21, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 10, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 30, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 24, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, November 27, 2024USE AMENDMENT FILED
Wednesday, November 27, 2024TEAS STATEMENT OF USE RECEIVED
Monday, February 10, 2025STATEMENT OF USE PROCESSING COMPLETE
Tuesday, February 11, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 24, 2025ASSIGNED TO EXAMINER
Tuesday, July 30, 2024PUBLISHED FOR OPPOSITION
Friday, March 21, 2025SOU TEAS EXTENSION RECEIVED
Wednesday, April 2, 2025SU - NON-FINAL ACTION - WRITTEN
Wednesday, April 2, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 2, 2025NON-FINAL ACTION E-MAILED
Thursday, April 10, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 28, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 28, 2025ASSIGNED TO LIE
Monday, April 28, 2025ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, May 20, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, May 20, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED
Monday, April 28, 2025NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, April 28, 2025TEAS/EMAIL CORRESPONDENCE ENTERED